Monthly Communication Report

Corporation:	Pfizer Canada ULC
Associated registration:	960525-15283-43
Communication date:	2025-10-24
Posted date:	2025-11-15

Designated Public Office Holders who participated in the communication:	Matthew  O'Connell , Deputy Director of Policy, Office of the Minister Finance Canada (FIN) Ian  Foucher, Chief of Staff to the Minister Finance Canada (FIN)
List of Details Subject matter Detail Government Procurement, Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance Advocacy related to the federal government consultation on the review of the Canada US Mexico Trade Agreement Federal-Provincial Relations, Foreign Affairs, Government Procurement, Health, International Trade, Research and Development, Taxation and Finance Advocacy with respect to Canada's proposed Countermeasures in Response to United States Tariffs on Canadian goods Health, Industry Engage the Federal Government on Health Canada’s Regulatory Innovation Agenda (Agile Licensing Modernization) to discuss opportunities for further harmonization; flexibility and predictability in the new regulatory framework being develop and its linkage to pillar 5 of the Biomanufacturing and Life Sciences Strategy. Health Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Drug Agency as well as the review times and processes conducted by Health Canada for the purpose of obtaining a notice of compliance. Industry The Department of Innovation, Science and Economic Development and the Innovation Agenda for the life sciences sector: policy or program initiatives to support life science research and development conducted in Canada and manufacturing capability.
Responsible Officer who filed this communication report:	An Van Gerven
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.